Stock IMNM IMMUNOME, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Immunome, Inc.

Equities

IMNM

US45257U1088

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
13.73 USD -3.72% Intraday chart for Immunome, Inc. -11.30% +28.32%
Apr. 25 Immunome, Inc. Appoints Sandra M. Swain to Board of Directors CI
Apr. 15 Guggenheim Starts Immunome With Buy Rating, $35 Price Target MT

Chart calendar Immunome, Inc.

3300c9cee360b5436067b7384.2PuMCwlkHDzFD8G5cUdM9GLHWOKJYrx3kRDEcK9YZ1w.mcjIODlQQ3efZ5nhNCgnwS-PB7ffFMgN4SmJRf0ZLD7sqP5uZCZICZZX-Q~8602f072145708380e46677dae01e2b1

Upcoming events on Immunome, Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-14 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)
2025-03-25 Q4 2024 Earnings Release (Projected)

Past events on Immunome, Inc.

2024-04-09 04:30 pm American Association for Cancer Research Meeting - Abstract No: 6026
2024-03-28 04:02 pm Q4 2023 Earnings Release
2024-03-12 04:20 pm Leerink Partners Global Biopharma Conference
2024-03-05 12:50 pm TD Cowen Health Care Conference - Panel
2024-02-08 09:30 am Guggenheim Healthcare Talks Biotechnology Conference
2024-01-11 10:30 am JPMorgan Healthcare Conference
2023-11-15 03:00 pm Stifel Healthcare Conference
2023-11-09 08:00 am Q3 2023 Earnings Release
2023-09-28 Extraordinary Shareholders Meeting - M&A Vote
2023-08-09 08:00 am Q2 2023 Earnings Release
2023-06-07 01:00 pm Annual General Meeting
2023-05-05 08:00 am Q1 2023 Earnings Release
2023-03-16 08:00 am Q4 2022 Earnings Release
2023-03-15 07:00 am World ADC London conference
2022-11-14 08:00 am Q3 2022 Earnings Release
2022-11-10 09:00 am SITC Meeting - Abstract Number: 823
2022-08-05 08:00 am Interim 2022 Earnings Release
2022-06-15 11:00 am Annual General Meeting
2022-06-09 02:30 pm Jefferies Healthcare Conference
2022-05-12 08:00 am Q1 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
2,10
- 		0,00
0,00
- 		0,00
0,00
- 		14,0
12,3
14.3%
8,00

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		0,00


-12,3
-11,3
-8.81%		-25,2
-27,5
8.27%		-36,9
-38,0
2.92%		-28,7
-29,3
1.96%
-114

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-17,8
-16,8
-5.9%		0,00
0,00
- 		-36,9
-38,0
2.92%		-107
-30,7
-247.93%
-109

Net income
Million USD		Released
Forecast
Spread 		-10,4


-17,8
-16,8
-5.9%		-24,7
-27,0
8.38%		-37,5
-38,0
1.28%		-107
-27,6
-286.53%
-114

EPS
USD		Released
Forecast
Spread 		-0,32


-5,26
-8,63
39.05%		-2,14
-2,32
7.76%		-3,09
-3,08
-0.49%		-5,38
-0,97
-454.64%
-2,00

Announcement Date09/09/2025/03/2128/03/2216/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		2,36
0,00
-





3,83
2,07
85.13%
2,50


2,25


2,25


1,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-7,84
-10,1
22.45%		-11,7
-8,78
-32.76%		-8,93
-10,8
17.67%		-8,53
-9,31
8.32%		-7,79
-8,90
12.46%		-4,47
-7,43
39.85%





-13,9
-10,4
-33.11%
-31,0


-25,5


-26,4


-31,0


-40,0

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread








-8,53
-9,31
8.33%		-7,79
-8,90
12.47%		-4,27
-7,43
42.55%





-92,6
-12,6
-638.03%
-30,4


-24,0


-25,1


-29,8


-37,8

Net income
Million USD		Released
Forecast
Spread 		-7,85
-10,1
22.35%		-11,7
-8,66
-34.64%		-8,92
-10,7
16.75%		-9,16
-9,31
1.64%		-7,79
-8,90
12.47%		-4,27
-7,43
42.55%


-4,35


-92,6
-12,0
-674.04%
-45,6


-20,6


-22,0


-26,2


-37,8

EPS
USD		Released
Forecast
Spread 		-0,65
-0,81
19.75%		-0,96
-0,69
-39.13%		-0,74
-0,93
20.43%		-0,75
-0,79
4.46%		-0,64
-0,68
5.19%		-0,35
0,59
-159.83%		-0,46
-0,16
-187.5%		-0,36


-4,22
-0,28
-1389.43%
-0,81


-0,37


-0,38


-0,46


-0,67

Announcement Date28/03/2212/05/2205/08/2214/11/2216/03/2305/05/2309/08/2309/11/2328/03/24-----

Upcoming sector events for Immunome, Inc.

2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 04:05 pm EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
2024-05-01 07:00 am NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release
More events

Past sector events for Immunome, Inc.

Today HITGEN INC.: Q1 2024 Earnings Release (Projected)
Today CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25 REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 04:05 pm PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. IMNM Stock
  4. Calendar Immunome, Inc.